GMP-Verlag celebrates its 25th anniversary in 2025. Thomas Peither, co-founder and long-standing board member of the publishing house, and Dr Petra Rempe, inspector of the Münster district government, look back together at the developments and milestones of the past 25 years and also venture a look into the future.

What level of requirements characterised GMP 25 years ago and where do we stand today? Which developments can be described as milestones and which regulations are decisive for this? Do GMP requirements improve drug quality and safety or do they make drugs prohibitively expensive? Which new technologies are shaping the future of pharmaceutical manufacturing and what are the associated GMP requirements? Both speakers have more than 25 years of professional experience in industry, consulting and authorities. They know GMP from different perspectives and have actively followed the developments in the pharmaceutical industry. Look forward to this GMP:talk with two experts who together have more than 50 years of GMP experience.